Form ARS Oruka Therapeutics, Inc. For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Oruka Therapeutics (ORKA)
- LTC Price Sits 89% Below Peak While Litecoin ETF Draws $5.4M and Pepeto Adds $10.3M Before Listing
- Parties seen as key to driving global governance, modernization
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
